Sharma K. Brain fog: Understanding the neurocognitive symptoms of COVID-19. Presentation at CMAAO (Confederation of Medical Associations in Asia and Oceania); June 26, 2021; virtual.
Invited speaker at the International weekly meeting for COVID-19 updates in collaboration with CMAAO (Confederation of Medical Associations in Asia and Oceania)
•Hospitalized COVID 19 patients commonly have neurologic complications.
•Myalgias, headache, encephalopathy, and dizziness may be most common, occurring in approximately one third of patients in China, Europe, and the United States.
•Dysgeusia or anosmia commonly reported.
•Stroke, movement disorders, motor and sensory deficits, ataxia, and seizures appear uncommon.
•Neurologic complications are higher in critically ill ICU patients
•This talk was to help highlight the pathophysiology of neuro COVID to shed insights on the care of patients with neurological symptoms post COVID